1-9 of 9
Valerie Tran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Social Determinants of Health and Geographic Location on Real-World Outcomes in AML Patients Undergoing Low-Intensity Chemotherapy

Valerie Tran, Gordon Smilnak, Nandan Srinivasa, Firas El Chaer, Michael Keng, Daniel Reed
Journal: Blood
Blood (2024) 144 (Supplement 1): 7904.
https://doi.org/10.1182/blood-2024-201720
Published: 2024
Journal Articles

IDH1/2 mut for the Win: Comprehensive Molecular Stratification of Venetoclax in Combination with Hypomethylating Agents in AML

Ian M. Bouligny, Graeme Murray, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Keri Maher
Journal: Blood
Blood (2022) 140 (Supplement 1): 6335–6336.
https://doi.org/10.1182/blood-2022-170907
Published: 2022
Journal Articles

Back in JAK - Real-World Analysis of JAK mut AML

Ian M. Bouligny, Graeme Murray, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Keri Maher
Journal: Blood
Blood (2022) 140 (Supplement 1): 11812–11813.
https://doi.org/10.1182/blood-2022-171165
Published: 2022
Journal Articles

Efficacy of Hypomethylating Agents with Venetoclax in TP53 mut AML

Ian M. Bouligny, Graeme Murray, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Keri Maher
Journal: Blood
Blood (2022) 140 (Supplement 1): 11842–11843.
https://doi.org/10.1182/blood-2022-170972
Published: 2022
Journal Articles

Healthcare Disparities Among African Americans Are Pervasive in the Treatment of AML

Ian M. Bouligny, Graeme Murray, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Keri Maher
Journal: Blood
Blood (2022) 140 (Supplement 1): 5281–5282.
https://doi.org/10.1182/blood-2022-171063
Published: 2022
Journal Articles

CPX-351 Appears Superior to 7+3 in Adverse-Risk AML and AML-MRC

Ian M. Bouligny, Graeme Murray, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Keri Maher
Journal: Blood
Blood (2022) 140 (Supplement 1): 11745–11746.
https://doi.org/10.1182/blood-2022-171129
Published: 2022
Journal Articles

Real-World Safety and Efficacy of Gemtuzumab Ozogamicin in Relapsed or Refractory AML

Ian M. Bouligny, Graeme Murray, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Keri Maher
Journal: Blood
Blood (2022) 140 (Supplement 1): 11744.
https://doi.org/10.1182/blood-2022-171018
Published: 2022
Journal Articles

Outcomes of FLAG-IDA Versus MEC in Relapsed or Refractory AML

Ian M. Bouligny, Graeme Murray, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Keri Maher
Journal: Blood
Blood (2022) 140 (Supplement 1): 11742–11743.
https://doi.org/10.1182/blood-2022-170836
Published: 2022
Journal Articles

Healthcare Disparities Among Minorities Treated with Venetoclax and Hypomethylating Agents in AML

Ian M. Bouligny, Graeme Murray, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Keri Maher
Journal: Blood
Blood (2022) 140 (Supplement 1): 13305–13306.
https://doi.org/10.1182/blood-2022-171223
Published: 2022